The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant

Affiliations

• ¹ Department of Internal Medicine, Erasmus Medical Center Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
• ² Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, Groningen, The Netherlands.
• ³ Center for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
• ⁴ Renal Transplant Unit, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
• ⁵ Department of Laboratory Medicine, Laboratory of Medical Immunology, Section Pediatric Infectious Diseases, Radboud Institute for Molecular Life Sciences, Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
• ⁶ Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
• ⁷ Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
• ⁸ Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
• ⁹ Department of Experimental Immunology, Amsterdam University Medical Center, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, The Netherlands.
• ¹⁰ Department of Health Evidence, Radboud University Medical Center, Radboud University, Nijmegen, The Netherlands.
• ¹¹ Department of Cardiology, Radboud University Medical Center, Radboud University, Nijmegen, The Netherlands.
• ¹² Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.